Análisis Argos
GEHC
GEHCEn su precio1 señal de riesgo
GE HealthCare Technologies Inc. · Healthcare
US$ 64.11
precio al 2026-07-28
Valor justo Argos*
US$ 45–54
vs. su valor justo
30% por encima
Score Argos
36/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (12.5%) en línea con lo que la empresa demuestra (7.4%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Sin recompensas destacadas.
Riesgos
!Cotiza 24% por encima de su valor justo.
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
!Piotroski F-Score débil (3/9)
VALOR3/6FUTURO2/6PASADO3/6SALUD2/6DIVIDENDO2/6
El Iris de calidad
VALOR3/6FUTURO2/6PASADO3/6SALUD2/6DIVIDENDO2/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoRetorno al accionista moderado
Score Argos36de 100En su precio
Ingresos5%
US$ 20.6 B
Margen operativo1%
13.4%
Flujo de caja libre3%
US$ 1.5 B
Deuda neta
US$ 5.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 29.2B
P/E14x
EV/EBITDA10.4x
FCF yield5.2%
ROIC13.5%
Margen operativo13.4%
Crecim. ingresos+4.8%/año
Piotroski F3/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 9 jul
GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics
GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.
prnewswire.com · 8 jul
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES, July 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws.   IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC.
prnewswire.com · 8 jul
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa., July 8, 2026 /PRNewswire/ -- Law Offices of Howard G.
businesswire.com · 8 jul
GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
CHICAGO & ROCHESTER, Minn.--(BUSINESS WIRE)--GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer. This collaboration is a direct result of the 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of.
businesswire.com · 8 jul
GE HealthCare to announce second quarter 2026 results on July 29, 2026
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will.
prnewswire.com · 7 jul
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
businesswire.com · 30 jun
GE HealthCare announces cash dividend for second quarter of 2026
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 payable on August 14, 2026, to all shareholders of record as of July 24, 2026.About GE HealthCare Technologies Inc.GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle.
zacks.com · 30 jun
GEHC Launches Allia Upgrade Pathways for Interventional Suites
GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enabled workflows while reducing construction and disruption.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.